COMP <GO>
SSII vs NPCE // ENTERPRISE SCALE & MARKET CAP
SS Innovations International Inc. (NASDAQ) VS. Neuropace Inc. (NASDAQ) • 15-METRIC TALLY: SSII 4
— NPCE 6
▲ ENTERPRISE SCALE & MARKET CAP LEADER: SSII
LAST: $2.38 (-2.46%) • MKT CAP: $477.2M
market-cap
$477.2M
LAST: $13.01 (+0.62%) • MKT CAP: $446.6M
market-cap
$446.6M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SSII VS. NPCE)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SSII | NPCE | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 46.00% | 77.20% | -31.20 | NPCE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -18.50% | -23.00% | +4.50 | SSII | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -4.65% | -2.54% | -2.11 | NPCE | /fcf-yield <GO> |
| Operating Margin | -19.30% | -16.30% | -3.00 | NPCE | /operating-margins <GO> |
| Net Profit Margin | -28.50% | -21.50% | -7.00 | NPCE | /net-margins <GO> |
| Revenue Growth (YoY) | 105.70% | 25.10% | +80.60 | SSII | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.47 | 0.20 | +7.27 | SSII | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 5/9 | -1.00 | NPCE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 37.7 | 48.7 | -11.00 | NPCE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $477.2M | $446.6M | $30.6M | SSII | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SSII REV | NPCE REV | SSII GROSS % | NPCE GROSS % | SSII FCF | NPCE FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $42.5M | $100.0M | 46.0% | 77.2% | -$22.2M | -$11.3M |
| FY 2024 | $20.6M | $79.9M | 40.9% | 73.9% | -$10.2M | -$18.3M |
| FY 2023 | $5.9M | $65.4M | — | — | -$15.4M | -$19.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SSII // BETA —
NPCE // BETA —